Wei-Shi Yeh, Ph.D. - Publications
Affiliations: | 2010 | Health Policy And Management | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Oncology, Public Health, EpidemiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2022 | Olchanski N, Lin PJ, Yeh WS, Kowal S, Cohen JT. When are breakthrough therapies cost-effective? Journal of Managed Care & Specialty Pharmacy. 28: 732-739. PMID 35737862 DOI: 10.18553/jmcp.2022.28.7.732 | 0.415 | |||
2016 | Lin PJ, Yeh WS, Neumann PJ. Willingness to Pay for a Newborn Screening Test for Spinal Muscular Atrophy. Pediatric Neurology. PMID 27769729 DOI: 10.1016/J.Pediatrneurol.2016.09.008 | 0.413 | |||
2015 | Lin P, Shi J, Yeh W, Neumann P. Willingness-to-Pay for Newborn Genetic Testing for Spinal Muscular Atrophy Value in Health. 18: A288-A289. DOI: 10.1016/J.Jval.2015.03.1682 | 0.403 | |||
2012 | Lin P, Bliss S, Fang C, Yeh W, Kowalski J, Neumann P. PSS16 Systematic Review of Cost-Utility Analyses in Age-Related Macular Degeneration Value in Health. 15: A252. DOI: 10.1016/j.jval.2012.03.1360 | 0.399 | |||
Show low-probability matches. |